Conexeu
Manufacturing · Nevada, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
50 W Liberty St Ste 880, Reno, Nevada, 8...Phone Number
(424) 333-5622Website
www.conexeu.comRevenue
-Stock Symbol
CNXUIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Conexeu
Conexeu is a regenerative medicine company developing CXU, a collagen-based extracellular matrix scaffold medical device candidate designed to support tissue regeneration. Its preclinical platform targets wound care, aesthetics, oral health, animal health, and 3D bioprinting through structural tissue restoration applications.Explore more
Conexeu Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Conexeu your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Conexeu has new funding data
Click to see if Conexeu had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Conexeu, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Conexeu
Earning: See what the market has to say on Conexeu recently announced quarterly report
Check if Conexeu has recently received funding, and reach out quickly before it becomes old news!
Check out if Conexeu is spiking on competitors!
Product Launch: Get notified when Conexeu launches new products
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Conexeu as Masked Content
Find 3 more new buyers
Compare Similar Companies to Conexeu
Compare insights from companies similar to Conexeu, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Conexeu is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Conexeu is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Conexeu.
Conexeu financials insights
Gather financial insights about Conexeu, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Private Equity
$1.3M
2026
Multiple Rounds
$2.8M
Conexeu Tech Stack
A closer look at the technologies used by Conexeu
Most Recent Scoops
Lateral Move
Executive Move
Executive Moves, Lateral Move, Board of Directors
Executive Move
Executive Moves, Board of Directors
Executive Move
Executive Moves, Board of Directors
Executive Move
Executive Moves, Board of Directors
Funding
Funding
Conexeu News & Media
A Weight-Loss Revolution Is Reshaping Bodies. This Preclinical Biotech Wants to Build What Comes Next
Issued on behalf of Conexeu Sciences Inc.The GLP-1s Are Creating Another Boom, a New $2 Billion Opportunity Exists in Aesthetics. Conexeu Is Building for It
Conexeu Sciences is aiming CXU™ at the largest unclaimed frontier in injectable aesthetics: restoring body fullness at a scale today's fillers were never built to reach. The move builds on the company's completed 12-month P.R.O.O.F.™ preclinical study Conexeu Sciences is aiming CXU™ at the largest unclaimed frontier in injectable aesthetics: restoring body fullness at a scale today's fillers were never built to reach. The move builds on the company's completed 12-month P.R.O.O.F.™ preclinical stOne Formula, One Platform: Inside the Preclinical Milestone Behind Conexeu's Move Into Medical Aesthetics
Issued on behalf of Conexeu Sciences Inc. Conexeu Sciences Inc. (NASDAQ: CNXU) completed the 12-month P.R.O.O.F phase of its CXU preclinical program, which met its objectives across three pillars, facial, body, and mechanical performance, as it advances a single-formulation regenerative...A $190 Billion Weight-Loss Boom Exposed a Tissue-Restoration Gap, and One Nasdaq Company Is Moving to Fill It
Issued on behalf of Conexeu Sciences Inc. Conexeu Sciences Inc. (NASDAQ: CNXU) completed the P.R.O.O.F phase of its CXU preclinical program, the evidence base behind a focused first move into a roughly $11 billion medical aesthetics injectable market, an opening the company argues today's...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Conexeu
Sign Up For FreeTo access detailed company insights
Conexeu is a regenerative medicine company developing CXU, a collagen-based extracellular matrix scaffold medical device candidate designed to support tissue regeneration. Its preclinical platform targets wound care, aesthetics, oral health, animal health, and 3D bioprinting through structural tissue restoration applications.... Read More
